Advertisement

Archives of Dermatological Research

, Volume 311, Issue 8, pp 629–636 | Cite as

Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial

  • Moustafa A. El TaiebEmail author
  • Eisa M. Hegazy
  • Hassan M. Ibrahim
  • Asmaa B. Osman
  • Manal Abualhamd
Original Paper
  • 142 Downloads

Abstract

Alopecia areata is a chronic relapsing autoimmune inflammatory hair disorder with no novel therapy. The objectives of this study are to compare the efficacy of topical calcipotriol vs narrow band ultraviolet B phototherapy (NB-UVB) in the treatment of alopecia areata and its correlation with serum vitamin D3 levels. A randomized-controlled trial has been conducted on 60 patients with scalp alopecia areata randomized into four groups; topical calcipotriol, NB-UVB, both and placebo. All patients were evaluated by assessment of severity of alopecia areata by severity of alopecia tool (SALT) score at baseline and 3 months after treatment and vitamin D3 levels at baseline and after 3 months. SALT score and vitamin D3 levels were significantly improved in all groups except placebo after treatment with (P = 0.026, P = 0.005, P = 0.004, P = 0.140) and (P = 0.028, P = 0.011, P = 0.003, P = 0.725), respectively. Combined therapy showed non-significant improvement in SALT score (P = 0.530, P = 0.643), respectively, and significant improvement in serum vitamin D3 levels than each line alone with (P = 0.021, P = 0.044), respectively. Both topical calcipotriol and NB-UVB are effective therapies in the treatment of AA and associated with improvement of SALT score and vitamin D3 levels.

Keywords

Alopecia areata Calcipotriol NB-UVB Vitamin D3 

Notes

References

  1. 1.
    Noso S, Park C, Babaya N, Hiromine Y, Harada T, Ito H, Taketomo Y, Kanto K, Oiso N, Kawada A, Suzuki T, Kawabata Y, Ikegami H (2015) Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata. J Clin Endocrinol Metab 100(5):1976–1983CrossRefGoogle Scholar
  2. 2.
    Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP (2017) Alopecia areata. Nat Rev Dis Primers 16(3):17011CrossRefGoogle Scholar
  3. 3.
    Strazzulla LC, Wang EHC, Avila L (2018) Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 78:1–12CrossRefGoogle Scholar
  4. 4.
    Olsen EA (2011) Investigative guidelines for alopecia areata. Dermatol Ther 24:311–319CrossRefGoogle Scholar
  5. 5.
    El Taieb MA, Ibrahim H, Nada EA, Seif Al-Din M (2017) Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation. Dermatol Ther 30(1):e12437CrossRefGoogle Scholar
  6. 6.
    Amin SS, Sachdeva S (2013) Alopecia areata: an update. J Pak Assoc Dermatol 23(2):209–220Google Scholar
  7. 7.
    Amor K, Rashid R, Mirmirani P (2010) Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J 16(2):3Google Scholar
  8. 8.
    Yilmaz N, Serarslan G, Gokce C (2012) Vitamin D concentrations are decreased in patients with alopecia areata. Vitam Trace Elem 1:1–4CrossRefGoogle Scholar
  9. 9.
    Cerman A, Solak SS, Altunay IK (2014) Vitamin D deficiency in alopecia areata. Br J Dermatol 170(6):1299–1304CrossRefGoogle Scholar
  10. 10.
    Mahamid M, Abu-Elhija O, Samamra M, Mahamid A, Nseir W (2014) Association between vitamin D levels and alopecia areata. Isr Med Assoc J. 16(6):367–370Google Scholar
  11. 11.
    Chen TC, Chimeh F, Lu Z, PersonKS ZhangA, KohnN Martinello S, Berkowitz R, Holick MF (2007) Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem 460:213–217CrossRefGoogle Scholar
  12. 12.
    Nancy AL, Yehuda S (2009) Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res 30:57–64CrossRefGoogle Scholar
  13. 13.
    Kim DH, Lee JW, Kim IS, Choi SY, Lim YY, Kim HM, Kim BJ, Kim MN (2012) Successful treatment of alopecia areata with topical calcipotriol. Ann Dermatol 24:341–344CrossRefGoogle Scholar
  14. 14.
    Çerman AA, Solak SS, Altunay İ, Küçükünal NA (2015) Topical calcipotriol therapy for mild-to-moderate alopecia areata: a retrospective study. J Drugs Dermatol 14(6):616–620Google Scholar
  15. 15.
    Macdonald-Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG (2003) Guidelines for the management of alopecia areata. Br J Dermatol 149(4):692–699CrossRefGoogle Scholar
  16. 16.
    Faul F, Erdfelder E, Lang AG, Buchner AG (2007) Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191CrossRefGoogle Scholar
  17. 17.
    El Taieb MA, Fayed HM, Aly SS, Ibrahim AK (2013) Assessment of serum 25-hydroxyvitamin D levels in children with atopic dermatitis: correlation with SCORAD index. Dermatitis 24:296–301CrossRefGoogle Scholar
  18. 18.
    Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, Keren A, Meyer KC, Wang E, Funk W, McElwee K, Paus R (2014) Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One 9(5):94260CrossRefGoogle Scholar
  19. 19.
    Bouillon R, Carmeliet G, Verlinden L, Van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726–776CrossRefGoogle Scholar
  20. 20.
    Antico A, Tampoia M, Tozzoli R, Bizzaro N (2012) Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 12:127–136CrossRefGoogle Scholar
  21. 21.
    Alkhalifah A, Alsantali A, Wang E, McElwee K, Shapiro J (2010) Alopecia areata update (Part 1). Clinical picture, histopathology and pathogenesis. J Am Acad Dermatol 62:177–188CrossRefGoogle Scholar
  22. 22.
    Segaert S, Simonart T (2008) The epidermal vitamin D system and innate immunity: some more light shed on this unique photoendocrine system dermatology. Dermatology 217(1):7–11CrossRefGoogle Scholar
  23. 23.
    D’Ovidio R, Vessio M, D’Ovidio FD (2013) Reduced level of 25-hydroxyvitamin D in chronic/relapsing alopecia areata. Dermatoendocrinol 5:271–273CrossRefGoogle Scholar
  24. 24.
    Narang T, Daroach M, Kumaran MS (2017) Efficacy of topical calcipotriol in management of alopecia areata: a pilot study. Dermatol Ther 30(3):12464CrossRefGoogle Scholar
  25. 25.
    Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M (2001) Extrarenal expression of 25-hydroxyvitamin D (3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888–894Google Scholar
  26. 26.
    Reichrath J, Schilli M, Kerber A, Bahmer FA, Czarnetzki BM, Paus R (1999) Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol 131:477–482CrossRefGoogle Scholar
  27. 27.
    Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, Chang S, Crumrine D, Bikle DD, Yoshizawa T, Kato S (2002) Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol 118:11–16CrossRefGoogle Scholar
  28. 28.
    Parsad D, Bhatnagar A, De D (2012) Narrowband ultraviolet B for the treatment of vitiligo. Expert Rev Dermatol 5(4):445–459CrossRefGoogle Scholar
  29. 29.
    Kaur S, Mahajan BB, Mahajan R (2015) Comparative evaluation of intralesional triamcinolone acetonide injection, narrow band ultraviolet B, and their combination in alopecia areata. Int J Trichology 7(4):148–155CrossRefGoogle Scholar
  30. 30.
    Dilek B, Demirsoy EO, Aktürk AS, Kıran R (2011) Narrowband ultraviolet B phototherapy for alopecia areata. Photodermatol Photoimmunol Photomed 27:325–327CrossRefGoogle Scholar
  31. 31.
    Bogh MKB, Gullstrand J, Svensson A, Ljunggren B, Dorkhan M (2012) Narrowband UVB three times a week more effective in treating vitamin D deficiency than 1600 IU oral vitamin D3/day: a randomized clinical trial. Br J Dermatol 166(6):1365–2133Google Scholar
  32. 32.
    Lehmann B (2009) Role of vitamin D3 pathway in healthy and diseased skin-facts, contradictions, and hypotheses. Exp Dermatol 18(2):97–108CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Dermatology, Venereology and Andrology, Faculty of MedicineAswan UniversityAswanEgypt
  2. 2.Dermatology, Venereology and Andrology, Faculty of MedicineSouth Valley UniversityQenaEgypt
  3. 3.Clinical Pathology, Faculty of MedicineAswan UniversityAswanEgypt
  4. 4.Dermatology, Administrative HospitalAswan UniversityAswanEgypt

Personalised recommendations